Reduction of IL9 may be an early response marker for interferon beta 1a treatment in multiple sclerosis patients
29th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis / 18th Annual Conference of Rehabilitation in MS, Danimarka, ss.450, (Tam Metin Bildiri)
- Yayın Türü: Bildiri / Tam Metin Bildiri
- Basıldığı Ülke: Danimarka
- Sayfa Sayıları: ss.450
- İstanbul Üniversitesi Adresli: Evet